EP0952846A4 - - Google Patents

Info

Publication number
EP0952846A4
EP0952846A4 EP95910999A EP95910999A EP0952846A4 EP 0952846 A4 EP0952846 A4 EP 0952846A4 EP 95910999 A EP95910999 A EP 95910999A EP 95910999 A EP95910999 A EP 95910999A EP 0952846 A4 EP0952846 A4 EP 0952846A4
Authority
EP
European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95910999A
Other versions
EP0952846A1 (fr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of EP0952846A1 publication Critical patent/EP0952846A1/fr
Publication of EP0952846A4 publication Critical patent/EP0952846A4/xx
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57554—Prolactin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP95910999A 1994-02-14 1995-02-14 Prolactine servant d'adjuvant pour vaccin Withdrawn EP0952846A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19635094A 1994-02-14 1994-02-14
US196350 1994-02-14
PCT/US1995/001866 WO1995021625A1 (fr) 1994-02-14 1995-02-14 Prolactine servant d'adjuvant pour vaccin

Publications (2)

Publication Number Publication Date
EP0952846A1 EP0952846A1 (fr) 1999-11-03
EP0952846A4 true EP0952846A4 (fr) 1999-11-03

Family

ID=22725034

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95910999A Withdrawn EP0952846A1 (fr) 1994-02-14 1995-02-14 Prolactine servant d'adjuvant pour vaccin

Country Status (5)

Country Link
EP (1) EP0952846A1 (fr)
JP (1) JPH09509415A (fr)
AU (1) AU700104B2 (fr)
CA (1) CA2183260A1 (fr)
WO (1) WO1995021625A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997040848A1 (fr) * 1996-04-30 1997-11-06 Genzyme Corporation Utilisation de la prolactine comme un antagoniste de tgf-beta
CA2277482A1 (fr) * 1997-01-21 1998-07-23 The United States Of America, Represented By The Secretary, Department O F Health And Human Services Stimulation de cellules hematopoietiques
WO2001014580A1 (fr) 1999-08-25 2001-03-01 Accuplex, L.L.C. Dosages diagnostiques de fluides biologiques secretes pour la detection d'etats infectieux et inflammatoires
EP1222275A2 (fr) 1999-10-22 2002-07-17 The Board of Regents of the University of Nebraska Isoforme de serum amyloide a decouverte dans le colostrum
AU2002364507A1 (en) * 2001-11-21 2003-06-10 Board Of Regents Of The University Of Nebraska Mammary-associated serum amyloid a3 promoter sequences and uses for same
US7368546B2 (en) 2003-01-21 2008-05-06 The Board Of Regents Of The University Of Nebraska Human SAA3 nucleic acid molecule, protein, and methods of use for same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002559A1 (fr) * 1988-09-15 1990-03-22 Public Health Laboratory Service Board Composition pharmaceutique permettant de provoquer un effet immunostimulant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725549A (en) * 1980-09-22 1988-02-16 The Regents Of The University Of California Human and rat prolactin and preprolactin cloned genes
US5028591A (en) * 1987-09-14 1991-07-02 Pitman-Moore, Inc. Method for stimulating the immune system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990002559A1 (fr) * 1988-09-15 1990-03-22 Public Health Laboratory Service Board Composition pharmaceutique permettant de provoquer un effet immunostimulant

Also Published As

Publication number Publication date
CA2183260A1 (fr) 1995-08-17
EP0952846A1 (fr) 1999-11-03
AU700104B2 (en) 1998-12-24
JPH09509415A (ja) 1997-09-22
WO1995021625A1 (fr) 1995-08-17
AU1876595A (en) 1995-08-29

Similar Documents

Publication Publication Date Title
DK105996A (fr)
BR9508234A (fr)
EP0666525A3 (fr)
DK0677466T3 (fr)
EP0669395A3 (fr)
EP0666470A3 (fr)
EP0665261A3 (fr)
DE69535748D1 (fr)
BR9509661A (fr)
FR2728886B1 (fr)
AR255595A1 (fr)
FR2725667B1 (fr)
TW270246B (fr)
ECSDI940181S (fr)
ECSDI940187S (fr)
IN191651B (fr)
IN179569B (fr)
ECSDI940193S (fr)
CU22453A3 (fr)
IN182372B (fr)
ECSMU940034U (fr)
ECSMU940030U (fr)
BR7402039U (fr)
BR7402097U (fr)
EP0662420A3 (fr)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960807

A4 Supplementary search report drawn up and despatched

Effective date: 19980826

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20000413

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000824